During the past decade, Phoebe Putney Memorial Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 37 clinical trials were completed, i.e. on average, 112.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 24 clinical trials were completed. i.e. 480% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Phoebe Putney Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 26 trials, followed by "SWOG Cancer Research Network" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "Celgene" with 4 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phoebe Putney Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Phoebe Putney Memorial Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Breast Cancer" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Invasive Breast Carcinoma" (4 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials). Many other conditions were trialed in "Phoebe Putney Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Phoebe Putney Memorial Hospital" are "Drug" (52 trials), "Other" (45 trials), "Biological" (21 trials), "Procedure" (9 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (30 trials), "Quality-of-Life Assessment" (15 trials), "Paclitaxel" (13 trials), "Carboplatin" (11 trials) and "Docetaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "Phoebe Putney Memorial Hospital" are 60 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "Phoebe Putney Memorial Hospital". undefined are not yet recruiting, 8 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Phoebe Putney Memorial Hospital, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Phoebe Putney Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Phoebe Putney Memorial Hospital has several departments that took part in Clinical trials: "Phoebe Cancer Center" - 7 trials